Junping Hu

ORCID: 0009-0007-6095-7735
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Phytochemistry and Biological Activities
  • Polysaccharides Composition and Applications
  • Cancer Treatment and Pharmacology
  • Natural Antidiabetic Agents Studies
  • Ginseng Biological Effects and Applications
  • Cancer survivorship and care
  • Polysaccharides and Plant Cell Walls
  • Liver Disease Diagnosis and Treatment
  • Natural product bioactivities and synthesis
  • Medicinal Plants and Bioactive Compounds
  • Tryptophan and brain disorders

Xinjiang Medical University
2024-2025

RELX Group (Netherlands)
2024

Objective To elucidate the metabolic mechanisms by which acteoside (ACT) isolated from Cistanche tubulosa alleviates cancer-related fatigue (CRF) in a murine model of colon cancer with cachexia. Methods BALB/c mice inoculated C26 cells were treated paclitaxel (PTX, 10 mg/kg) and ACT (100 alone or combination for 21 days. Fatigue-associated behaviors, tumor inhibition rate, skeletal muscle morphology assessed hematoxylin-eosin (H&E) staining electron microscopy evaluated. Finally,...

10.3389/fphar.2024.1370264 article EN cc-by Frontiers in Pharmacology 2025-01-13

ABSTRACT Introduction Cistanche deserticola Ma (CD), an edible and medicinal plant native to Xinjiang, Inner Mongolia, Gansu in China, is rich bioactive polysaccharides known for their health‐promoting properties. The of C. (CDPs) have been shown possess a range beneficial activities, including immunomodulatory, anti‐aging, antioxidant, anti‐osteoporosis effects. Objective This study seeks identify the optimal conditions extracting CDPs using hot water. Additionally, it aims evaluate...

10.1002/pca.3512 article EN Phytochemical Analysis 2025-01-23

Diabetic nephropathy (DN) is a prevalent complication and serious microvascular of diabetes mellitus. After previous studies, we found that phenylethanol glycosides (CPhGs) derived from

10.1089/jmf.2024.k.0175 article EN Journal of Medicinal Food 2024-10-14
Coming Soon ...